JNJ vs BAX
By Alex · Tickerpine
Johnson & Johnson vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BAX |
|---|---|---|
| Price | $254.66 | $22.04 |
| Market cap | $613.02B | $11.38B |
| P/E ratio | 29.5 | — |
| ROE | 26.42% | -15.01% |
| Profit margin | 21.83% | -9.70% |
| Revenue growth | 9.90% | 2.90% |
| Dividend yield | 2.10% | 0.91% |
| Beta | 0.26 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BAX in plain English
- JNJ is the bigger company — about 53.9× the market cap of BAX.
- JNJ earns a higher return on equity (26% vs -15%).
- JNJ is growing revenue faster (10% vs 3%).
- JNJ has the higher dividend yield (2.10% vs 0.91%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.